Galderma Group AG
SIX:GALD
Fundamental Analysis

Revenue & Expenses Breakdown
Galderma Group AG
Balance Sheet Decomposition
Galderma Group AG
Current Assets | 1.8B |
Cash & Short-Term Investments | 457m |
Receivables | 905m |
Other Current Assets | 481m |
Non-Current Assets | 10.8B |
Long-Term Investments | 1m |
PP&E | 577m |
Intangibles | 10B |
Other Non-Current Assets | 238m |
Free Cash Flow Analysis
Galderma Group AG
Free Cash Flow |
Earnings Waterfall
Galderma Group AG
Revenue
|
4.4B
|
Cost of Revenue
|
-1.4B
|
Gross Profit
|
3.1B
|
Operating Expenses
|
-2.4B
|
Operating Income
|
675m
|
Other Expenses
|
-444m
|
Net Income
|
231m
|
GALD Profitability Score
Profitability Due Diligence
Galderma Group AG's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
Score
Galderma Group AG's profitability score is 51/100. The higher the profitability score, the more profitable the company is.
GALD Solvency Score
Solvency Due Diligence
Galderma Group AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Galderma Group AG's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
GALD Price Targets Summary
Galderma Group AG
According to Wall Street analysts, the average 1-year price target for GALD is 114.58 CHF with a low forecast of 106.05 CHF and a high forecast of 134.4 CHF.
Dividends
Current shareholder yield for GALD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?